GSK Investigational Site

Koebenhavn Ø 2100

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis — Completed